Columbia Integrated Training Program in Infectious Diseases Research
Project Number5T32AI100852-12
Former Number5T32AI100852-10
Contact PI/Project LeaderUHLEMANN, ANNE-CATRIN Other PIs
Awardee OrganizationCOLUMBIA UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
PROJECT ABSTRACT
This is a renewal application from the Columbia University Irving Medical Center (CUIMC) for a post-doctoral
training grant in Infectious Diseases entitled “Columbia Integrated Training Program in Infectious Disease
Research (TP-IDR)”. Drs. Anne-Catrin Uhlemann and Magdalena Sobieszczyk will serve as principal
investigators (PIs) under the multiple PI NIH model. Both are established investigators with complementary
research interests and longstanding commitments to the training of new investigators. The goal of this proposal
is to train post-doctoral fellows with MD or MD-PhD degrees who are destined for academic infectious disease
careers. The interdisciplinary program is designed to provide the necessary skillset to successfully pursue
translational research whether this research be primarily basic, implementation science or
clinical/epidemiological. The dramatic advances in the fields of microbial genomics and biomedical informatics
and the potential application of these rapidly evolving tools to translational research has necessitated a
reappraisal of our approach to training new investigators. The ongoing recruitment to CUMC of world class
investigators (e.g., Dr. David Ho, Aaron Diamond AIDS Research Center in Division of Infectious Diseases; Dr.
Megan Sykes, Center for Translational Immunology) combined with pre-existent strengths in Infectious
Diseases, pathogen discovery (Dr. IanLipkin, Center for Infection and Immunity), Biomedical Informatics (Dr.
George Hripcsak) and retroviral-host protein interactions (Dr. Stephen Goff, Howard Hughes Medical Institute)
has allowed us to construct a Training Program that can recognize and nurture talented individuals. The TP-IDR,
is not only producing new investigators but is also stimulating new interest in Infectious Disease research more
broadly at CUIMC. Resubmission is being sought to continue the success demonstrated thus far and to secure
its future. Drs. Uhlemann and Sobieszczyk will continue to co-chair the Executive Steering Committee that serves
as the governing body. A Diversity Enhancement and Recruitment and Selection Committees will insure that
our applicant pool is strong and diverse. A dynamic mix of well-established and junior investigators has been
assembled to form a close-knit, dedicated faculty. Trainees selected to the TP-IDR have a choice of laboratory-
based, health disparities/ implementation science, or clinical/epidemiological-based research projects and have
the option of obtaining a Master’s degree in either Epidemiology or Biomedical Informatics. Didactic conferences
and integrated TP-IDR seminars complement the educational experience. Mentorship, training, career
development and feedback are thorough. An Advisory Committee, including members from within and outside
the institution, will assist with oversight of the program. Institutional support is strong and broad-based. The
intersection of microbial genomics, biomedical informatics and pathogenesis with clinical investigation,
translational research, implementation science, epidemiology and global health form the conceptual vision of the
TP-IDR. This program permits us to train the academic Infectious Disease leaders of the future.
Public Health Relevance Statement
PROJECT NARRATIVE
This is an application for a renewal from the Columbia University Irving Medical Center (CUIMC) for a post-
doctoral training grant entitled the “Columbia Integrated Training Program in Infectious Disease Research”
(Drs. Anne-Catrin Uhlemann and Magdalena Sobieszczyk, principal investigators). The goal of this proposal is
to train postdoctoral fellows with MD or MD-PhD degrees in state-of-the-art infectious disease research
technologies and information handling. This interdisciplinary program will provide trainees with the necessary
skillset to become leaders in the field of Infectious Diseases and thereby be in position to meet the infectious
disease threats of the future and protect the public health.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
621889815
UEI
QHF5ZZ114M72
Project Start Date
01-June-2013
Project End Date
31-May-2028
Budget Start Date
01-June-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$188,707
Direct Costs
$198,216
Indirect Costs
$12,817
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$188,707
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5T32AI100852-12
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5T32AI100852-12
Patents
No Patents information available for 5T32AI100852-12
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5T32AI100852-12
Clinical Studies
No Clinical Studies information available for 5T32AI100852-12
News and More
Related News Releases
No news release information available for 5T32AI100852-12
History
No Historical information available for 5T32AI100852-12
Similar Projects
No Similar Projects information available for 5T32AI100852-12